Home » Topics » Regulatory » EMA

EMA
RSS

Alcon withdraws application to extend European approval of Opatanol

Feb. 28, 2006

February meeting of European Committee for Orphan Medicinal Products

Feb. 18, 2005

Positive opinion for new Thyrogen indication in Europe

Jan. 27, 2005

EMEA warns on new safety findings for valdecoxib, parecoxib sodium

Dec. 27, 2004

EMEA warns on coadministration of Reyataz and Norvir with omeprazole

Dec. 27, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

E.U. regulators to review long-term cardiovascular safety data for COX-2 inhibitors

Oct. 13, 2004

March 2004 meeting of European Committee for Orphan Medicinal Products

March 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...